Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 912 across all filing types
Latest filing 2025-12-29 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Closure of Trading Window
Regulatory Filings
2025-12-29 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (583 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no indication of any report, announcement, or regulatory filing content. Given the lack of any financial or corporate information, this document does not fit into any specific report category and defaults to the fallback category for miscellaneous filings.
2025-12-29 English
Newspaper Clipping-Information regarding Extra Ordinary General Meeting to be held through VC/OAVM.
Regulatory Filings
2025-12-13 English
Copy of Newspaper Publication
Regulatory Filings Classification · 85% confidence The document is a covering letter from Wanbury Limited to the stock exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosing newspaper clippings of an Extra-Ordinary General Meeting notice. It is a regulatory announcement rather than the actual EGM materials or a formal proxy statement. It does not contain substantive report data, financial statements, or the full meeting agenda – instead it simply submits the public notice clipping to comply with listing rules. Therefore, it best fits the "Regulatory Filings" category (RNS).
2025-12-13 English
Notice of Book Closure for the purpose of Extra-Ordinary General Meeting (EOGM) to be held on 5th January, 2026 through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
Regulatory Filings
2025-12-12 English
Notice of the Extra Ordinary General Meeting of Wanbury Limited to be held on 5th January, 2026 through Video Conferencing (VC) / Other Audio Visual Means (OVAM).
Regulatory Filings
2025-12-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.